CYBB and chronic granulomatous disease: The first two rounds of clinical trial conducted at NIH (USA) in 1995 and 1998 targeting autosomal recessive (p47phox deficiency) and X-linked CGD (gp91phox deficiency) with γ-retroviral vectors were performed on a total of ten patients without any pre-conditioning.